Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2<em>H</em>)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1<em>H</em>,5<em>H</em>)-pyrimidinedione and naloxone/naltrexone

Publication date: Available online 2 June 2022Source: Bioorganic ChemistryAuthor(s): Shu-Yu Lin, Ya-Wen Tien, Yi-Yu Ke, Yung-Chiao Chang, Hsiao-Fu Chang, Li-Chin Ou, Ping-Yee Law, Jing-Hua Xi, Pao-Luh Tao, Horace H. Loh, Yu-Sheng Chao, Chuan Shih, Chiu…